Endogenous metabolism in endothelial and immune cells generates most of the tissue vitamin B3 (nicotinamide)

Julianna D. Zeidler, Claudia C.S. Chini, Karina S. Kanamori, Sonu Kashyap, Jair M. Espindola-Netto, Katie Thompson, Gina Warner, Fernanda S. Cabral, Thais R. Peclat, Lilian Sales Gomez, Sierra A. Lopez, Miles K. Wandersee, Renee A. Schoon, Kimberly Reid, Keir Menzies, Felipe Beckedorff, Joel M. Reid, Sebastian Brachs, Ralph G. Meyer, Mirella L. Meyer-FiccaEduardo Nunes Chini

Research output: Contribution to journalArticlepeer-review

Abstract

In mammals, nicotinamide (NAM) is the primary NAD precursor available in circulation, a signaling molecule, and a precursor for methyl-nicotinamide (M-NAM) synthesis. However, our knowledge about how the body regulates tissue NAM levels is still limited. Here we demonstrate that dietary vitamin B3 partially regulates plasma NAM and NAM-derived metabolites, but not their tissue levels. We found that NAD de novo synthesis from tryptophan contributes to plasma and tissue NAM, likely by providing substrates for NAD-degrading enzymes. We also demonstrate that tissue NAM is mainly generated by endogenous metabolism and that the NADase CD38 is the main enzyme that produces tissue NAM. Tissue-specific CD38-floxed mice revealed that CD38 activity on endothelial and immune cells is the major contributor to tissue steady-state levels of NAM in tissues like spleen and heart. Our findings uncover the presence of different pools of NAM in the body and a central role for CD38 in regulating tissue NAM levels.

Original languageEnglish (US)
Article number105431
JournaliScience
Volume25
Issue number11
DOIs
StatePublished - Nov 18 2022

Keywords

  • Biochemistry
  • Biological sciences
  • Immunology
  • Molecular biology

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Endogenous metabolism in endothelial and immune cells generates most of the tissue vitamin B3 (nicotinamide)'. Together they form a unique fingerprint.

Cite this